SCOPUS 정보 검색 플랫폼

Volumn 15, Issue 9, 2001, Pages 1466-1470

Evaluating treatment strategies in advanced Waldenström macroglobulinemia: Use of quality-adjusted survival analysis

(10) Levy V a,b Porcher, R a,b Leblond, V c Fermand, J P a Cazin, B d Maloisel, F e Harousseau, J L f Remenieras, L g Guibon, O h Chevret, S a,b

a SAINT LOUIS HOSPITAL (France)

b INSERM (France)

c PITIÉ SALPÊTRIÈRE HOSPITAL (France)

d LILLE UNIVERSITY HOSPITAL (France)

e HÔPITAL DE HAUTEPIERRE (France)

f HÔTEL DIEU (France)

g LIMOGES UNIVERSITY HOSPITAL (France)

h Laboratoire Schering SA (France)

Author keywords

Macroglobulinemia; Q TWiST; Quality of life; Waldenstr m

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; PREDNISONE;

ALOPECIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTANTS AND COEFFICIENTS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; HUMAN; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SURVIVAL RATE; SURVIVAL TIME; SYMPTOM; WALDENSTROEM MACROGLOBULINEMIA;

EID: 17644446693 PISSN: 08876924 EISSN: None Source Type: Journal
DOI: 10.1038/sj.leu.2402221 Document Type: Article

Times cited : (15)

References (30)

1
- 0028295179
- Waldenstrom's macroglobulinemia
- (1994) Blood , vol.83 , pp. 1452-1459
- Dimopoulos, M.A.¹ Alexanian, R.²

2
- 0031788917
- Bolus administration of cladribine in the treatment of Waldenstrom macroglobulinaemia
- (1998) Br J Haematol , vol.103 , pp. 690-695
- Liu, E.S.¹ Burian, C.² Miller, W.E.³ Saven, A.⁴

3
- 0028014636
- Fludarabine therapy in a patient with progressive symptomatic Waldenstrom's macroglobulinemia
- (1994) Acta Haematol Pol , vol.25 , pp. 63-67
- Halaburda, K.¹ Hellmann, A.²

4
- 0033017554
- Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenstrom's macroglobulinemia
- (1999) Eur J Haematol , vol.63 , pp. 35-41
- Hellmann, A.¹ Lewandowski, K.² Zaucha, J.M.³ Bieniaszewska, M.⁴ Halaburda, K.⁵ Robak, T.⁶

5
- 0028837270
- Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: Identification of prognostic factors
- (1995) Ann Oncol , vol.6 , pp. 49-52
- Dimopoulos, M.A.¹ Weber, D.² Delasalle, K.B.³ Keating, M.⁴ Alexanian, R.⁵

6
- 0028173001
- Primary therapy of Waldenstrom's macroglobulinemia with 2-chlorodeoxyadenosine
- (1994) J Clin Oncol , vol.12 , pp. 2694-2698
- Dimopoulos, M.A.¹ Kantarjian, H.² Weber, D.³ O'Brien, S.⁴ Estey, E.⁵ Delasalle, K.⁶ Rose, E.⁷ Cabanillas, F.⁸ Keating, M.⁹ Alexanian, R.¹⁰

7
- 1842406646
- First-line treatment of Waldenstrom's disease with cladribine. Arbeitsgemeinschaft Medikamentose Tumortherapie
- (1997) Ann Hematol , vol.74 , pp. 7-10
- Fridrik, M.A.¹ Jager, G.² Baldinger, C.³ Krieger, O.⁴ Chott, A.⁵ Bettelheim, P.⁶

8
- 0032976375
- Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenstrom's macroglobulinemia, and mantle-cell lymphoma
- (1999) J. Clin Oncol , vol.17 , pp. 546-553
- Foran, J.M.¹ Rohatiner, A.Z.² Coiffier, B.³ Barbui, T.⁴ Johnson, S.A.⁵ Hiddemann, W.⁶ Radford, J.A.⁷ Norton, A.J.⁸ Tollerfield, S.M.⁹ Wilson, M.P.¹⁰ Lister, T.A.¹¹

9
- 0032794517
- A comparison of two approaches for assessing patient importance weights to conduct an extended Q-TWiST analysis
- (1999) Qual Life Res , vol.8 , pp. 197-207
- Schwartz, C.E.¹ Mathias, S.D.² Pasta, D.J.³ Colwell, H.H.⁴ Rapkin, B.D.⁵ Genderson, M.W.⁶ Henning, J.M.⁷

10
- 0032526165
- Quality adjusted survival analysis with repeated quality of life measures
- (1998) Stat Med , vol.17 , pp. 1215-1229
- Glasziou, P.P.¹ Cole, B.F.² Gelber, R.D.³ Hilden, J.⁴ Simes, R.J.⁵

11
- 21844481778
- Comparing treatments using quality-adjusted survival: The Q-TWiST method
- (1995) Am Stat , vol.49 , pp. 161-169
- Gelber, R.D.¹ Cole, B.F.² Gelber, S.³ Goldhirsch, A.⁴

12
- 0026016685
- Quality-of-life-adjusted survival for comparing cancer treatments. A commentary on TWiST and Q-TWiST
- (1991) Cancer , vol.67 , Issue.SUPPL. 3 , pp. 851-854
- Feldstein, M.L.¹

13
- 34548144505
- Results of a multicentric randomized study comparing the efficacy of fludarabine to that of cyclophosphamide, doxorubicine and prednisone in 92 patients with Waldensrtöm's macroglobulinemia in first relapse or disease
- on behalf of the French Cooperative group on CLL and Macroglobulinemia. (in press)
- Leblond, V.¹ Lévy, V.² Maloisel, F.³ Cazin, B.⁴ Fermand, J.P.⁵ Harousseau, J.L.⁶ Remenieras, L.⁷ Porcher, R.⁸ Gardembas, M.⁹ Marit, G.¹⁰ Deconinck, E.¹¹ Desablens, B.¹² Guilhot, F.¹³ Philippe, G.¹⁴ Stamatoullas, A.¹⁵ Guibon, O.¹⁶

14
- 0024994259
- Quality adjusted survival analysis
- (1990) Stat Med , vol.9 , pp. 1259-1276
- Glasziou, P.P.¹ Simes, R.J.² Gelber, R.D.³

15
- 33845382806
- Nonparametric estimation from incomplete observations
- (1958) J Am Stat Assoc , vol.54 , pp. 457-481
- Kaplan, E.L.¹ Meier, P.²

16
- 0345676551
- Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: An aid to clinical decision making
- (1998) J Clin Oncol , vol.16 , pp. 2339-2344
- Cole, B.F.¹ Solal-Celigny, P.² Gelber, R.D.³ Lepage, E.⁴ Gisselbrecht, C.⁵ Reyes, F.⁶ Sebban, C.⁷ Sugano, D.⁸ Tendler, C.⁹ Goldhirsch, A.¹⁰

17
- 0033024372
- Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the pediatric oncology group study 8821
- (1999) J Clin Oncol , vol.17 , pp. 2144-2152
- Parsons, S.K.¹ Gelber, S.² Cole, B.F.³ Ravindranath, Y.⁴ Ogden, A.⁵ Yeager, A.M.⁶ Chang, M.⁷ Shuster, J.⁸ Weinstein, H.J.⁹ Gelber, R.D.¹⁰

18
- 0031950081
- Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma
- (1998) J Clin Oncol , vol.16 , pp. 2834-2839
- Zee, B.¹ Cole, B.² Li, T.³ Browman, G.⁴ James, K.⁵ Johnston, D.⁶ Sugano, D.⁷ Pater, J.⁸

19
- 0031778016
- Activity of fludarabine in previously treated Waldenstrom's macroglobulinemia: A report of 71 cases
- Groupe Cooperatif Macroglobulinemie.
- (1998) J Clin Oncol , vol.16 , pp. 2060-2064
- Leblond, V.¹ Ben-Othman, T.² Deconinck, E.³ Taksin, A.L.⁴ Harousseau, J.L.⁵ Delgado, M.A.⁶ Delmer, A.⁷ Maloisel, F.⁸ Mariette, X.⁹ Morel, P.¹⁰ Clauvel, J.P.¹¹ Duboisset, P.¹² Entezam, S.¹³ Hermine, O.¹⁴ Merlet, M.Y.¹⁵ Akoub-Agha, I.¹⁶ Guibon, O.¹⁷ Caspard, H.¹⁸ Fort, N.¹⁹

20
- 0029165950
- Treatment of Waldenstrom's macroglobulinemia with very low doses of alpha interferon
- (1995) Leuk Lymphoma , vol.19 , pp. 337-342
- Legouffe, E.¹ Rossi, J.F.² Laporte, J.P.³ Isnard, F.⁴ Oziol, E.⁵ Fabbro, M.⁶ Janbon, C.⁷ Joudan, J.⁸ Najman, A.⁹

21
- 0025921423
- macroglobulinemia: Long-term results with the M-2 protocol
- (1991) Cancer Invest , vol.9 , pp. 1-7
- Case D.C., Jr.¹ Ervin, T.J.² Boyd, M.A.³ Redfield, D.L.⁴ Waldenstrom's⁵

22
- 0032890555
- Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemia
- (1999) Bone Marrow Transplant , vol.23 , pp. 747-749
- Martino, R.¹ Shah, A.² Romero, P.³ Brunet, S.⁴ Sierra, J.⁵ Domingo-Albos, A.⁶ Fruchtman, S.⁷ Isola, L.⁸

23
- 0029779273
- A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer
- (1996) J Natl Cancer Inst , vol.88 , pp. 1039-1045
- Gelber, R.D.¹ Goldhirsch, A.² Cole, B.F.³ Wieand, H.S.⁴ Schroeder, G.⁵ Krook, J.E.⁶

24
- 0031459657
- Adjuvant cyclophosphamide, methotrexate and fluorouracil for node-positive breast cancer: A lifetime cost-utility analysis based on a modified Q-TWIST method
- (1997) Eur J Clin Pharmacol , vol.53 , pp. 281-282
- Trippoli, S.¹ Becagli, P.² Messori, A.³

25
- 0031660952
- Adjuvant interferon treatment for melanoma
- (1998) Hematol Oncol Clin North Am , vol.12 , pp. 823-833
- Agarwala, S.S.¹ Kirkwood, J.M.²

26
- 0029739081
- Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: An Eastern Cooperative Oncology Group study
- (1996) J Clin Oncol , vol.14 , pp. 2666-2673
- Cole, B.F.¹ Gelber, R.D.² Kirkwood, J.M.³ Goldhirsch, A.⁴ Barylak, E.⁵ Borden, E.⁶

27
- 0030595678
- Re: A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer
- (1996) J Natl Cancer Inst , vol.88 , pp. 1686
- DeCosse, J.J.¹ Cennerazzo, W.J.²

28
- 0030861185
- Randomized comparison of total androgen blockade alone versus combined with weekly epirubicin in advanced prostate cancer
- (1997) Eur Urol , vol.32 , Issue.SUPPL. 3 , pp. 81-85
- Pummer, K.¹ Lehnert, M.² Stettner, H.³ Hubmer, G.⁴

29
- 0032894994
- Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: Comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer
- European Organization for Research and Treatment of Cancer.
- (1999) Prostate , vol.38 , pp. 100-109
- Rosendahl, I.¹ Kiebert, G.M.² Curran, D.³ Colen, B.F.⁴ Weeks, J.C.⁵ Denis, L.J.⁶ Hall, R.R.⁷

30
- 0034193341
- Self-report measures of patient utility: Should we trust them?
- (2000) J Clin Epidemiol , vol.53 , pp. 469-476
- Hanita, M.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.